[HTML][HTML] Individualized conservative therapeutic strategies for adenomyosis with the aim of preserving fertility

L Han, Y Liu, K Lao, J Jiang, C Zhang, Y Wang - Frontiers in Medicine, 2023 - frontiersin.org
Adenomyosis is a diffuse or localized organic disease caused by benign invasion of
endometrial glands and stroma into the myometrium. It is a common disease that seriously …

Long‐term durability of uterine artery embolisation for treatment of symptomatic adenomyosis

J Ma, B Brown, E Liang - Australian and New Zealand Journal …, 2021 - Wiley Online Library
Background Failing conservative therapies, uterine artery embolisation (UAE) has been
proposed as a uterine‐sparing option for treatment of symptomatic adenomyosis. UAE …

Heat can treat: Long-term follow-up results after uterine-sparing treatment of adenomyosis with radiofrequency thermal ablation in 60 hysterectomy candidate patients

AK Stepniewska, S Baggio, R Clarizia, F Bruni… - Surgical …, 2022 - Springer
Background Adenomyosis may induce pelvic pain, abnormal uterine bleeding or bulk
symptoms. If hormonal treatment proves ineffective or contraindicated, hysterectomy may be …

[HTML][HTML] Minimally invasive adenomyomectomy via a laparoscopic-assisted approach compared to a laparoscopic or laparotomic approach

JW Ahn, SG You, EB Go, SH Lee, JS Kim… - Taiwanese Journal of …, 2021 - Elsevier
Objective The present study assessed the safety and benefits of laparoscopic-assisted
adenomyomectomy compared to laparoscopic or laparotomic adenomyomectomy. Materials …

Asherman syndrome in adenomyosis treated with uterine artery embolization: incidence predictive factors

Y Wang, W Lyu, W Xu, Y Yu - La radiologia medica, 2020 - Springer
Abstract Purpose To investigate Asherman syndrome (AS) related to potential factors during
uterine artery embolization (UAE) treatment of adenomyosis. Materials and methods This is …

Investigation of the 12-month efficacy and safety of low-dose mifepristone in the treatment of painful adenomyosis

SY Chen, MD Zhao, WT Sun, LB Zhu… - Reproductive and …, 2022 - journals.lww.com
Objective: To study the 12-month effects and possible mechanisms of low-dose mifepristone
in the treatment of adenomyosis. Methods: Patients included in this retrospective study had …

The Advantages and Disadvantages of Uterine Artery Embolization in Women with Adenomyosis: What's New?

BL Knapman, J Abbott, MA Vyas - Current Obstetrics and Gynecology …, 2021 - Springer
Abstract Purpose of Review This review will examine the use of uterine artery embolization
(UAE) for the management of adenomyosis (AUB-A) and evaluate its advantages and …

Evaluation of Junctional Zone Differential and Ratio as Possible Markers of Clinical Efficacy in Uterine Artery Embolization of Adenomyosis

K Turtóczki, H Cho, S Dastaran, PN Kaposi… - 2024 - researchsquare.com
Materials and methods Patients who underwent UAE for adenomyosis from 2008-2021 were
evaluated. Adenomyosis was diagnosed based on JZmax, JZdiff, and JZratio measured on …

The Contribution of Uterine Artery Embolization as a Safe Treatment Option for Uterine Fibroids

P Tsikouras, A Bothou, X Anthoulaki, A Chalkidou… - Fibroids, 2020 - books.google.com
Uterine fibroids have remarkably heterogeneous clinical characteristics with unknown exact
etiology. The treatment of fibroids should be individualized based on their size, location …

복강경이용자궁선근증절제와복강경혹은개복을통한자궁선근증절제술의비교

유슬기 - 2021 - oak.ulsan.ac.kr
Objective: To assess the safety and benefit of laparoscopic assisted adenomyomectomy
compared with laparoscopic or laparotomic adenomyomectomy. Materials and methods This …